Skip to main content
Farmacosmo logo

Farmacosmo — Investor Relations & Filings

Ticker · ZJ1 ISIN · IT0005487670 LEI · 815600ABEDB6F0BDDE28 XMIL Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2025-03-06 Board/Management Inform…
Country IT Italy
Listing XMIL ZJ1

About Farmacosmo

https://www.farmacosmo.com/

Farmacosmo is an e-commerce company that operates an online platform for health, beauty, and personal care products. The company's core business is the online sale of a broad range of items, including parapharmaceuticals, supplements, cosmetics, personal care products, baby supplies, and pet care essentials. Managing its platform in-house, Farmacosmo offers a catalog of over 80,000 products from various brands. The company aims to provide a comprehensive wellness destination by combining the offerings of a pharmacy and a cosmetics retailer, supported by expert advice from professionals.

Recent filings

Filing Released Lang Actions
Farmacosmo Conferisce L’incarico Di Specialist A Integrae Sim S.P.A.
Board/Management Information Classification · 99% confidence The document is a formal announcement ('COMUNICATO STAMPA') dated March 6, 2025, regarding a corporate action: Farmacosmo appointing Integrae SIM S.p.A. as its new Specialist, effective March 11, 2025. This type of announcement, which details changes in roles related to market making or advisory services, is a specific corporate event disclosure. It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV). Since it concerns a specific operational/advisory change and is a formal regulatory disclosure (referenced under art.17 of Euronext Growth Milan Issuer Regulations), it fits best under the general category for regulatory announcements that don't match other specific codes. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a specific, non-standard corporate disclosure, although it could also be argued as a type of Capital/Financing Update (CAP) if the Specialist role is tied to capital market activities, but RNS is safer for general regulatory notices. However, upon reviewing the definitions, this is a specific corporate event announcement, not a general regulatory filing fallback. Since there is no specific code for 'Change in Market Advisor/Specialist', and it is a formal communication to the market, RNS (Regulatory Filings) serves as the best fit among the provided codes for a specific, non-standard corporate disclosure.
2025-03-06 Italian
Farmacosmo S.p.A. - Internal Dealing
Director's Dealing Classification · 100% confidence The document text contains Italian regulatory headers ('Informazione Regolamentata') and the subject line explicitly states 'Farmacosmo S.p.A. - Internal Dealing'. Furthermore, the template title is 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The filing code for Director's Dealing is DIRS.
2025-02-17 Italian
Farmacosmo: Risultati Del Terzo Periodo Di Esercizio Dei “Warrant Farmacosmo 2022-2025”
Regulatory Filings Classification · 95% confidence The document is a formal communication from Farmacosmo S.p.A. titled "Farmacosmo: Risultati Del Terzo Periodo Di Esercizio Dei 'Warrant Farmacosmo 2022-2025'". It reports the outcome (zero exercises) of a specific warrant exercise period. This type of announcement, which details the result of a corporate action (warrant exercise) and is disseminated via regulatory channels (Euronext Growth Milan), fits best under the general category of regulatory announcements or specific corporate actions. Since there is no specific code for 'Warrant Exercise Results', and it is a formal, time-sensitive disclosure, it falls under the broad 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous official announcements not covered by other specific codes like DIV, SHA, or CAP. The document length is moderate (5167 chars), but its primary function is regulatory disclosure of a corporate event outcome.
2025-02-03 Italian
Farmacosmo S.p.A. - Internal Dealing
Director's Dealing Classification · 100% confidence The document is an official notification published on January 31, 2025, with the subject line 'Farmacosmo S.p.A. - Internal Dealing' (Oggetto: Farmacosmo S.p.A. - Internal Dealing). It explicitly uses the template titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). Therefore, the appropriate filing code is DIRS.
2025-01-31 Italian
Farmacosmo: Approvato Il Calendario Degli Eventi Societari 2025
Report Publication Announcement Classification · 99% confidence The document is a formal communication ('COMUNICATO STAMPA') issued by Farmacosmo S.p.A. on January 29, 2025, regarding the approval of the 'Calendario Degli Eventi Societari 2025' (Calendar of Corporate Events 2025). This calendar lists future dates for Board meetings, earnings releases (Q4 2024 data review, Q1-Q3 2025 data review), and the Annual Shareholders' Meeting (Assemblea degli Azionisti) for approving the 2024 Financial Statements. Since this document is an announcement detailing the schedule of future mandatory corporate events and financial reporting dates, it functions as a general regulatory disclosure. It is not the actual financial report (10-K or IR), nor is it a specific announcement about dividends (DIV), management changes (MANG), or insider trading (DIRS). Given its nature as a scheduled corporate event announcement that doesn't fit the highly specific categories like AGM-R, ER, or IR, the most appropriate classification is the general regulatory filing category, RNS (Regulatory Filings), as per the fallback rule for miscellaneous regulatory announcements.
2025-01-29 Italian
Farmacosmo In Corso Terzo Periodo Esercizio Warrant
Share Issue/Capital Change Classification · 99% confidence The document is an official communication (Informazione Regolamentata) from Farmacosmo S.p.A. dated January 15, 2025. The subject ('Oggetto') explicitly states: 'Farmacosmo In Corso Terzo Periodo Esercizio Warrant' (Farmacosmo Warrant Exercise Period Underway). The text details the terms, dates (January 15 – January 31, 2025), exercise price (€3.38), and procedures for exercising the 'WARRANT FARMACOSMO 2022-2025'. This clearly relates to the issuance or change in capital structure involving warrants, which falls under the 'Capital/Financing Update' category (CAP). Although it involves warrants, it is not a general announcement of capital raising (CAP) but a specific corporate action related to existing securities, which is often classified under financing/capital changes. Given the options, CAP is the most appropriate fit for an announcement detailing the exercise period of outstanding warrants.
2025-01-15 Italian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.